Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1989-04-12
1989-12-19
Dixon, Jr., William R.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424470, 424472, A61K 924
Patent
active
048881783
ABSTRACT:
A galenic formulations are disclosed with programmed release, to be administered orally containing as the active ingredient a compound having antiphlogistic, analgesic and antipyretic activity like, for instance, an arylacetic or an arylpropionic acid, and pharmaceutically acceptable salts thereof. In these new formulations, a portion of the active ingredient is released in a short time, so that the drug can quickly develop its therapeutic action and reach the necessary hematic levels, while the remaining portion of the active constituent is released in a longer interval of time so as to allow therapeutic coverage until subsequent administration. The therapeutic coverage can even last twenty-four hours. Thus, the new galenic formulations object of the present invention are suitable for administration one a day.
REFERENCES:
patent: 2793979 (1957-05-01), Svedres
patent: 3044938 (1962-07-01), Halley
patent: 4012498 (1977-03-01), Kornblum et al.
patent: 4167588 (1979-09-01), Sheth et al.
patent: 4572833 (1986-02-01), Pedersen et al.
patent: 4720387 (1988-01-01), Sakamoto et al.
Marchi Egidio
Rotini Leone G.
Alfa Wassermann S.p.A.
Dixon Jr. William R.
Sohn Miriam
LandOfFree
Galenic formulations with programmed release containing naproxen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galenic formulations with programmed release containing naproxen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic formulations with programmed release containing naproxen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1901736